Pharmacy Information

Cariprazine (Reagila) is a new second-generation antipsychotic which is licensed to treat schizophrenia in adults (over 18 years). It is only available as an oral capsule and is presented in [...]

A new formulation of clozapine will be available from June 2019 consisting of an oral dispersible tablet marketed as Zaponex orodispersible tablets by the company Leyden Delta BV. The special [...]

Buprenorphine has been long-established as an opioid substitution medication available as sublingual tablets. It is an opioid partial agonist/antagonist with strong receptor binding affinity and [...]

The Department of Health & Social Care has provided the following official guidance regarding the management of possible medicines shortages resulting from the UK leaving the European Union [...]

The EU Falsified Medicines Directive (2011/62/EU) (FMD) was adopted by the UK in 2011 and will be implemented on 9th February 2019, when the Delegated Regulation on ‘safety features’ will be [...]

The NMC standards for medicines management have been withdrawn from 28th January 2019. This means that these standards will no longer be recognised as the professional guidance for nurses and [...]

The Royal Pharmaceutical Society has recently revised and updated its guidance on the safe and secure handling of medicines, formally known as The Duthie Report, and it has produced a framework [...]

Homely remedies, also known as discretionary medicines, are non-prescription medicines that can be used to treat minor self-limiting health problems. Examples would include mild painkillers such [...]

The main pharmacy providers to care homes have announced that they will cease to provide monitored dosage systems (MDS), also known as compliance aids or blister packs, to care homes. This is [...]

The Royal College of Psychiatry defines high dose antipsychotics use as: ‘A total daily dose of a single antipsychotic which exceeds the upper limit stated in the SPC or BNF with respect to age [...]